[Basis for using terrilytin in the combined therapy of periodontosis].
D000287:Administration, Topical; D000681:Amylases / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D005122:Exudates and Transudates / Q000187:drug effects; D006801:Humans; D066298:In Vitro Techniques; D009824:Ointments; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D010510:Periodontal Diseases / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D009824:Ointments; C009402:amylase, phosphates, proteases drug combinations; D000681:Amylases; D010447:Peptide Hydrolases
Obosnovanie primeneniia terrilitina v kompleksnoĭ terapii parodontoza.